Shanghai ZJ Bio-Tech Co. Ltd. A (SHG:688317) — Market Cap & Net Worth
Market Cap & Net Worth: Shanghai ZJ Bio-Tech Co. Ltd. A (688317)
Shanghai ZJ Bio-Tech Co. Ltd. A (SHG:688317) has a market capitalization of $508.65 Million (CN¥3.48 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #12351 globally and #3635 in its home market, demonstrating a 12.61% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai ZJ Bio-Tech Co. Ltd. A's stock price CN¥18.31 by its total outstanding shares 189843712 (189.84 Million). Also see Shanghai ZJ Bio-Tech Co. Ltd. A total assets for a full breakdown of the balance sheet.
Shanghai ZJ Bio-Tech Co. Ltd. A Market Cap History: 2021 to 2026
Shanghai ZJ Bio-Tech Co. Ltd. A's market capitalization history from 2021 to 2026. Data shows change from $1.32 Billion to $508.65 Million (-20.45% CAGR). Also see 688317 cash flow metrics for how efficiently the company converts equity into cash flow.
Shanghai ZJ Bio-Tech Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Shanghai ZJ Bio-Tech Co. Ltd. A stock quote for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
4.49x
Shanghai ZJ Bio-Tech Co. Ltd. A's market cap is 4.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.32 Billion | $2.02 Billion | $758.52 Million | 0.65x | 1.74x |
| 2022 | $879.62 Million | $2.33 Billion | $760.27 Million | 0.38x | 1.16x |
| 2023 | $579.01 Million | $274.33 Million | -$136.86 Million | 2.11x | N/A |
| 2024 | $451.43 Million | $178.65 Million | -$127.46 Million | 2.53x | N/A |
| 2025 | $560.32 Million | $124.91 Million | -$34.30 Million | 4.49x | N/A |
Competitor Companies of 688317 by Market Capitalization
Companies near Shanghai ZJ Bio-Tech Co. Ltd. A in the global market cap rankings as of September 24, 2026. Review Shanghai ZJ Bio-Tech Co. Ltd. A (688317) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Shanghai ZJ Bio-Tech Co. Ltd. A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #122 globally with a market cap of $180.30 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #237 globally with a market cap of $105.52 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #122 | Abbott Laboratories | NYSE:ABT | $180.30 Billion | $103.69 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $90.77 |
| #237 | Stryker Corporation | NYSE:SYK | $105.52 Billion | $275.09 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Shanghai ZJ Bio-Tech Co. Ltd. A Historical Marketcap From 2021 to 2026
Between 2021 and today, Shanghai ZJ Bio-Tech Co. Ltd. A's market cap moved from $1.32 Billion to $ 508.65 Million, with a yearly change of -20.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥508.65 Million | -9.22% |
| 2025 | CN¥560.32 Million | +24.12% |
| 2024 | CN¥451.43 Million | -22.03% |
| 2023 | CN¥579.01 Million | -34.18% |
| 2022 | CN¥879.62 Million | -33.19% |
| 2021 | CN¥1.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Shanghai ZJ Bio-Tech Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $508.65 Million USD |
| MoneyControl | $508.65 Million USD |
| MarketWatch | $508.65 Million USD |
| marketcap.company | $508.65 Million USD |
| Reuters | $508.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shanghai ZJ Bio-Tech Co. Ltd. A
Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. The company offers nucleic acid and real-time PCR kits, as well as consumables. It serves public health safety and clinical diagnostics sectors. The company was founded in 2005 and is based in Shanghai, China.